Loading
A phase 2 trial of Propranolol, Paclitaxel / nab-paclitaxel and Carboplatin in Ovarian cancer, run by Bai-Rong Xia, now recruiting.
Chemotherapy Combined With Propranolol Hydrochloride as Neoadjuvant Therapy for Advanced High-grade Serous Ovarian Cancer is a phase 2 interventional study registered as NCT07125391 by Bai-Rong Xia, with 136 participants planned, started 2025-06-20 and due to reach its primary completion in 2026-08-30. Interventions recorded: Propranolol Hydrochloride, Paclitaxel liposome, Carboplatin. Conditions recorded: Ovarian Cancer.
Linked to the drug Propranolol because the registry names it among its interventions and Ovarian cancer among its conditions. Registry record only: no result has been read by an editor.
Shares High-grade serous ovarian cancer, Ovarian cancer and the tag pipeline.
Shares Propranolol (Hemangeol) and the tag pipeline.
Shares High-grade serous ovarian cancer, Ovarian cancer and the tag pipeline.
Shares Paclitaxel / nab-paclitaxel, Carboplatin and the tag pipeline.
Shares High-grade serous ovarian cancer, Ovarian cancer and the tag pipeline.
Shares High-grade serous ovarian cancer, Ovarian cancer and the tag pipeline.
Shares Paclitaxel / nab-paclitaxel, Carboplatin and the tag pipeline.
Shares Ovarian cancer and the tag pipeline.